Germany has secured new antibody-based corona drugs. Health Minister Spahn confirmed the purchase. Karl Lauterbach (SPD) praised the investment.
- The federal government has bought new Corona * drugs for 400 million euros
- Health Minister Jens Spahn confirmed the purchase. (see first report)
- There are two substances from US manufacturers. They are not yet approved in the EU. (see update from January 24th, 8:08 pm)
Update from January 24th, 8:08 pm: Jens Spahn has raised hopes with the purchase of corona drugs (see initial reports). There are now more details about the treatment method that once was too Donald Trump should have helped known. The US FDA has already approved these drugs through an emergency procedure. An evaluation by the European authorities is still pending.
Corona antibody drug: Karl Lauterbach (SPD) praises Spahn’s approach
The preparations can still be used in clinics. An application takes place after individual benefit-risk assessment by the treating physicians, announced the Federal Ministry of Health (BMG) at the request of the dpa. FDP health expert Andrew Ullman points out the need for further investigations. The data situation is thin. “If Spahn wants to approach the matter professionally, he has no choice but to test the drug as part of a study approval at university clinics.”
According to BMG, two different monoclonal antibody-containing drugs were purchased from US manufacturers:
- The antibody Bamlanivimab the Eli Lilly company
- and the antibodies to be administered simultaneously Casirivimab and Imdevimab of the producer Regeneron
This is finally proven Effect of the substances but not yet. “According to the available studies, the medication could possibly help to limit the amount of virus in the body and thus have a positive influence on the course of the disease, ”a ministry spokesman explained the current state of research.
SPD health expert Karl Lauterbach nevertheless praised Spahn’s approach. The study situation points to one positive influence the medication, Lauterbach told the partner newspapers of the Neue Berliner Redaktionsgesellschaft (Monday edition). “Because of the high cost of these drugs, the clinics would probably not have bought this supply. So I welcome the action. “
Corona funds: Spahn announces purchase of new Covid drug
First report from January 24th, 9:58 a.m .:
Berlin – The corona– Numbers in Germany go – probably thanks to the Lockdowns – slowly back. However, there is still great concern. Especially the new ones Mutations * of the virus recently ensured that the federal and state governments extended the applicable measures to mid-February – for the time being. At the same time, vaccination against Corona is only starting slowly. There is still too little vaccine * available.
At this point in time there is now a message that gives hope: Germany has secured a new corona drug. The Minister of Health confirmed Jens Spahn now towards the Picture on sunday. Accordingly, the remedy is a novel one Drug on antibody–Base.
“From next week, the monoclonal antibodies will be used in Germany as the first country in the EU. Initially in university clinics, ”says Spahn zur BamS. In total, the federal government has bought 200,000 cans for 400 million euros.
Corona agent based on antibodies acts “like a passive vaccination”
“They act like a passive vaccination”Spahn now explained about the remedy. Accordingly, the antibody drug can especially help in the treatment of high-risk patients. If they are administered in the early phase of an illness, the agent could help prevent a severe course of Covid, said Spahn.
A similar corona agent probably also helped Donald Trump
According to media reports, the then US president was also there Donald Trump * treated with this type of antibody after his corona infection. Trump received the REGN-COV2 antibody cocktail from the US company Regeneron at the beginning of October.
The active ingredient of REGN-COV2 is a combination of two specially developed Antibodiesthat bind to the so-called spike protein of the coronavirus and thus deform its structure. This is to prevent the coronavirus from attacking human cells. According to Regeneron, the combination of two different antibodies should prevent the Sars-COV2 virus from mutating. (rjs / af / dpa) * merkur.de is part of the nationwide Ippen digital editorial network.
List of rubric lists: © Matthias Balk / dpa